Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory

GlobeNewswire January 3, 2018

BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biotech Showcase

GlobeNewswire December 28, 2017

BioSig Technologies Issues Shareholder Letter for 2017

GlobeNewswire December 21, 2017

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

GlobeNewswire November 14, 2017

IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors

GlobeNewswire November 10, 2017

BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28

GlobeNewswire November 8, 2017

BioSig Technologies Partners with Sherpa Technology Group

GlobeNewswire November 2, 2017

BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System

GlobeNewswire October 26, 2017

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

GlobeNewswire October 24, 2017

BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022

GlobeNewswire October 19, 2017

BioSig Technologies to Present at the Dawson James Small Cap Growth Conference

GlobeNewswire October 13, 2017

BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer

GlobeNewswire October 11, 2017

BioSig Technologies to Present at The MicroCap Conference on October 5th in New York City at the Essex House

Accesswire September 26, 2017

BioSig Technologies Enters into Strategic Development Work with Health Research International

GlobeNewswire July 11, 2017

Novel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017

GlobeNewswire June 26, 2017

BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget

GlobeNewswire June 13, 2017

BioSig Technologies Launches New Corporate Website

GlobeNewswire June 8, 2017

BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe

GlobeNewswire May 31, 2017

PURE EP System Featured in the Journal of Innovations in Cardiac Rhythm Management

GlobeNewswire May 9, 2017

BioSig Technologies to Present at Heart Rhythm Society’s Scientific Sessions on May 11 in Chicago

GlobeNewswire May 5, 2017